Markets concluded the week with slight declines, influenced by mixed macroeconomic indicators, a depreciating rupee, and persistent uncertainty regarding the timing of a potential India–US trade agreement, which has contributed to a subdued investor outlook. The Nifty decreased by 0.31% to 25,966, and the Sensex dropped 0.40% to 84,929 for the week, indicating a phase of consolidation after recent fluctuations.
On Friday, Indian equity benchmarks concluded a four-day losing streak, finishing robustly, supported by a stable rupee, favorable global indicators, and the Bank of Japan’s policy decision aligning with expectations, which enhanced market sentiment. The Sensex increased by 448 points, representing a 0.53% rise, concluding at 84,929.36. Meanwhile, the Nifty 50 saw an advancement of 151 points, or 0.58%, finishing at 25,966.40. The overall market performance surpassed that of the leading indices, as evidenced by the BSE Midcap and Smallcap indices, which increased by 1.26% and 1.25%, respectively.
” Indian equities exhibited a cautious demeanor throughout the week, influenced by ongoing FII outflows, a depreciation of the rupee to record lows, and prevailing global uncertainties. Initial trading sessions experienced downward pressure due to increasing Japanese bond yields and anticipations of Bank of Japan tightening, which heightened risk-averse sentiment throughout emerging markets. Domestic benchmarks exhibited a range-bound movement with a negative bias, even as RBI’s currency stabilisation efforts provided some support and there was optimism regarding the earnings recovery in H2FY26. The sentiment strengthened on Friday following a weaker US CPI report, which heightened expectations for a more accommodative approach from the Federal Reserve. “Bargain hunting and declining crude prices contributed to a late rebound in large-cap stocks, reducing the majority of the week’s losses,” stated Vinod Nair.
In light of current market conditions – Here is a compilation of stocks that may capture investor attention and are expected to experience notable activity today.
Equities to Monitor :
- Tata Steel announced an investment of Rs 1,354.94 crore in its wholly owned overseas subsidiary, T Steel Holdings Pte Ltd, via an equity share subscription. The acquisition involved 149 crore shares, each with a face value of $0.1008, ensuring that the subsidiary remains wholly owned by the company post-transaction.
- Infosys ADRs reached a new 52-week high of $30 on Friday, experiencing a 40% surge that led to two trading halts due to significant volatility affecting the session.
- Piramal Finance is set to divest its entire 14.72% stake in Shriram Life Insurance Company to Sanlam Emerging Markets (Mauritius) for Rs 600 crore, which suggests a valuation of approximately Rs 4,000 crore for the insurer.
- Indian Hotels board has approved the entry into a Sale and Purchase Agreement (SPA) for the divestment of 1.6 crore equity shares, representing a 25.52% stake in Taj GVK Hotels & Resorts (TajGVK).
- RITES has disclosed that it has signed a Memorandum of Understanding with the government of Botswana to support the advancement and modernization of the country’s railway and transport infrastructure.
- ICICI Prudential AMC has filed draft documents with SEBI to obtain approval for launching a specialized investment fund in accordance with the regulator’s recently established framework.
- Kotak Mahindra Bank – The Reserve Bank on Friday disclosed that it has imposed a monetary penalty of Rs 61.95 lakh on Kotak Mahindra Bank due to non-compliance with regulations related to basic savings bank deposit (BSBD) accounts, business correspondents, and credit information companies.
- Vedanta – Fitch Ratings has upgraded the outlook for Vedanta Resources to positive, emphasizing progress in deleveraging, enhanced liquidity, and better visibility on earnings.
- Tata Chemicals has disclosed that its wholly owned subsidiary, Tata Chemicals International Pte Ltd, has executed a share purchase agreement to acquire the complete equity stake in Singapore-based Novabay Pte Ltd, a manufacturer of premium-grade sodium bicarbonate.
- Granules India – The US Food and Drug Administration (FDA) has finalized a Good Manufacturing Practices (GMP) and Prior Approval Inspection at Granules Life Sciences (GLS), located in Hyderabad, and has noted five procedural observations.